Phase II clinical trials showed that participants using retatrutide lost 17.5% of their weight after 24 weeks and 24.2% after 48 weeks
Reframe the hold period from an inconvenience to a deliberate pause in your morning routine
INTELLECTUAL PROPERTY RIGHTS : The Website and its entire contents, features, and functionality (including but not limited to all information, software, text, displays, images, video, and audio, and the design, selection, and arrangement thereof) are owned by the Company, its licensors, or other providers of such material and are protected by United States and international copyright, trademark, patent, trade secret, and other intellectual property or proprietary rights laws
More clinical trials aimed at obese people in Asia and Africa are expected to prove its effectiveness and safety